Brian Keegan

Brian Keegan

The Tax Take: The new government will have to be able to withstand a budget vote

The Tax Take: The new government will have to be able to withstand a budget vote

And that means keeping a lot of people happy on tax, including the troika

The Tax Take

The Tax Take

As Britain weighs up whether to remain in the EU, would you want to join? House of Cards author Michael Dobbs’s argument is one that counts

The Tax Take: Dear Minister-to-be...

The Tax Take: Dear Minister-to-be...

Some sound advice for a new Minister for Finance

The Tax Take: Finding a voice on Brexit

The Tax Take: Finding a voice on Brexit

‘Four freedoms’ hold the key to free cross-border trade

Brian Keegan: The Tax Take

Brian Keegan: The Tax Take

No one likes paying PRSI, but it does at least come with some benefits

Brian Keegan: The Tax Take

Brian Keegan: The Tax Take

Britain comes first on the burning issue of tax

Brian Keegan: The Tax Take

Brian Keegan: The Tax Take

As the election draws near, the tax proposals from our politicians deserve scrutiny

Brian Keegan: Too big a bite for us?

Brian Keegan: Too big a bite for us?

This tax tussle could leave Apple – and other US firms - with a sour taste

Brian Keegan: The Tax Take

Brian Keegan: The Tax Take

Taxes introduced to change behaviour patterns can have unexpected results

Brian Keegan: The Tax Take

Brian Keegan: The Tax Take

It feels like we are in a bygone era, but next month’s Vat receipts will be the true test of recovery

Brian Keegan: What are 2016's major tax trends?

Brian Keegan: What are 2016's major tax trends?

Our tax expert gazes into his crystal ball

Brian Keegan: The Tax Take

Brian Keegan: The Tax Take

When domestic tax comes under the ECB microscope, you can’t blame the Department of Finance for being irked

Brian Keegan: The Tax Take

Brian Keegan: The Tax Take

The political parties all have tax policy proposals, but beware of false promises

Brian Keegan: Time to let our hair down prudently

Brian Keegan: Time to let our hair down prudently

Last week’s announcement that tax receipts are up led to comparisons with the overflowing coffers of 2006 – the harbingers of the bust. While that is unfair, we still must be cautious

Brian Keegan: Corporation tax not the only lure for Pfizer

Brian Keegan: Corporation tax not the only lure for Pfizer

Pfizer and Allergan already have a substantial presence here